Anna Juncker‐Jensen
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Cancer, Hypoxia, and Metabolism
- Immunology top 10%
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 6
- Pancreatic and Hepatic Oncology Research 2
-
- Protease and Inhibitor Mechanisms 9
- Co-authors
- Ewa Zając (4 shared papers)James P. Quigley (4 shared papers)Elena I. Deryugina (4 shared papers)Tatyana A. Kupriyanova (4 shared papers)Lisa Welter (1 shared paper)Leif R. Lund (7 shared papers)Petra Minder (1 shared paper)Bernhard Schweighofer (2 shared papers)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Molecular Cancer Therapeutics (2 papers)Blood (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
Anna Juncker‐Jensen
26 papers receiving 822 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 224
- Immunology 280
- Immunology and Allergy 67
- Oncology 236
- Rehabilitation 27
Countries citing papers authored by Anna Juncker‐Jensen
This map shows the geographic impact of Anna Juncker‐Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Juncker‐Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Juncker‐Jensen more than expected).
Fields of papers citing papers by Anna Juncker‐Jensen
This network shows the impact of papers produced by Anna Juncker‐Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Juncker‐Jensen. The network helps show where Anna Juncker‐Jensen may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Juncker‐Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 255 | |
| 2 | 2013 | 218 | |
| 3 | 2013 | 70 | |
| 4 | 2008 | 48 | |
| 5 | 2023 | 39 | |
| 6 | 2006 | 38 | |
| 7 | 2007 | 37 | |
| 8 | 2011 | 26 | |
| 9 | 2012 | 23 | |
| 10 | 2023 | 21 | |
| 11 | 2023 | 17 | |
| 12 | 2008 | 10 | |
| 13 | 2012 | 7 | |
| 14 | 2018 | 5 | |
| 15 | 2023 | 3 | |
| 16 | 2019 | 3 | |
| 17 | 2012 | 2 | |
| 18 | 2019 | 2 | |
| 19 | 2019 | 2 | |
| 20 | 2023 | 1 |
About Anna Juncker‐Jensen
Anna Juncker‐Jensen is a scholar working on Oncology, Cancer Research, Immunology, Hematology and Immunology and Allergy, having authored 27 papers that have together received 833 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Immune cells in cancer (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cell Adhesion Molecules Research (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Ovarian cancer diagnosis and treatment (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Cancer Research (224 citations), Immunology (280 citations), Immunology and Allergy (67 citations), Oncology (236 citations) and Rehabilitation (27 citations). Anna Juncker‐Jensen has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Ewa Zając, James P. Quigley, Elena I. Deryugina, Tatyana A. Kupriyanova, Lisa Welter, Leif R. Lund, Petra Minder, Bernhard Schweighofer, Kasper Almholt and John Rømer. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Molecular Cancer Therapeutics, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.